Listed by the USPTO as WESTON, ALYSSA G
Tech Center 1700 • Art Units: 1600 1632 1633 1653 1699 1797
This examiner grants 60% of resolved cases
WESTON, ALYSSA G is assigned to Tech Center 1700 and Art Unit 1600. The record covers 116 resolved cases, with an allowance rate of 59.5% and a median of 1276 days to allowance. The interview lift is 49.0%, showing a substantial positive association between interviews and allowance outcomes in this record.
The listed companies are The University of Toledo, Autolus Limited, and Nissan Chemical Corporation. The listed firms are MACMILLAN SOBANSKI & TODD, LLC, MARSHALL, GERSTEIN & BORUN LLP, and NORTON ROSE FULBRIGHT US LLP. Practitioners may find interviews particularly valuable for narrowing disagreements before prosecution extends further. The 1276-day median also favors early identification of claim features that can be supported with clear technical explanations and targeted amendments.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19101972 | FASL-MODIFIED PLG SCAFFOLDS ENHANCES DIFFERENTIATION OF STEM CELL DERIVED BETA CELLS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 16899302 | CPF1-RELATED METHODS AND COMPOSITIONS FOR GENE EDITING | Non-Final OA | EDITAS MEDICINE, INC. |
| 18576909 | METHODS FOR DIFFERENTIATING AND SCREENING STEM CELLS | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18029750 | METHODS FOR IDENTIFYING MODULATORS OF NATURAL KILLER CELL INTERACTIONS | Final Rejection | The Johns Hopkins University |
| 18382626 | CD47 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES | Non-Final OA | President and Fellows of Harvard College |
| 18266712 | TAU BIOSENSOR CELL LINES | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
| 18949699 | COMPOSITIONS AND MATERIALS FOR REGENERATION OF SKELETAL MUSCLE | Non-Final OA | Purdue Research Foundation |
| 17928674 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS USING CRISPR-BASED BASE EDITOR SYSTEMS | Final Rejection | The Trustees of Columbia University in the City of New York |
| 17053752 | MESENCHYMAL STROMAL CELL EXOSOME-TREATED MONOCYTES AND USES THEREOF | Non-Final OA | Children's Medical Center Corporation |
| 18323196 | QUALITY CONTROL SUBSTANCE USED IN URINE SEDIMENT ANALYZER | Final Rejection | ARKRAY, Inc. |
| 17912480 | ISCHEMIC HEART DISEASE ANIMAL MODEL USING 3-DIMENSIONAL BIOPRINTED OCCLUDE, AND MANUFACTURING METHOD THEREFOR | Non-Final OA | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy59.5% of resolved applications examined by Alyssa G Weston were allowed (116 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +49.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Alyssa G Weston took 1,276 days on average from filing to allowance.
Alyssa G Weston examines applications in Art Unit 1600 in Tech Center 1700 (Chemistry & Materials).
